MENU
+Compare
CSBR
Stock ticker: NASDAQ
AS OF
Aug 28, 04:59 PM (EDT)
Price
$6.62
Change
+$0.02 (+0.30%)
Capitalization
91M

CSBR Champions Oncology Forecast, Technical & Fundamental Analysis

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs... Show more

Industry: #Biotechnology
CSBR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for CSBR with price predictions
Aug 27, 2025

CSBR's RSI Oscillator ascends from oversold territory

The RSI Oscillator for CSBR moved out of oversold territory on August 04, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 27 similar instances when the indicator left oversold territory. In of the 27 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

The Moving Average Convergence Divergence (MACD) for CSBR just turned positive on August 13, 2025. Looking at past instances where CSBR's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CSBR advanced for three days, in of 239 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 27, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on CSBR as a result. In of 115 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

CSBR moved below its 50-day moving average on August 25, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for CSBR crossed bearishly below the 50-day moving average on July 31, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CSBR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CSBR broke above its upper Bollinger Band on August 18, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for CSBR entered a downward trend on August 12, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CSBR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (24.155) is normal, around the industry mean (19.660). P/E Ratio (20.000) is within average values for comparable stocks, (54.828). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.654). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (1.653) is also within normal values, averaging (303.787).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CSBR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
CSBR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

CSBR is expected to report earnings to fall 185.71% to 5 cents per share on September 10

Champions Oncology CSBR Stock Earnings Reports
Q3'25
Est.
$0.06
Q2'25
Missed
by $0.13
Q1'25
Beat
by $0.37
Q4'24
Beat
by $0.08
Q3'24
Beat
by $0.14
The last earnings report on July 23 showed earnings per share of -7 cents, missing the estimate of 5 cents. With 11.54K shares outstanding, the current market capitalization sits at 91.00M.
A.I. Advisor
published General Information

General Information

a provider of advanced technology solutions and services for oncology drugs

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
One University Plaza
Phone
+1 201 808-8400
Employees
230
Web
https://www.championsoncology.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EZOO0.25N/A
N/A
EZAGOO LTD.
HKUOY16.50N/A
N/A
Hakuhodo Dy Holdings, Inc.
SQZB0.03N/A
N/A
SQZ Biotechnologies Company
IHRTB1.04N/A
N/A
iHeartMedia, Inc.
SPXCY25.51-0.02
-0.08%
Singapore Exchange Ltd.

CSBR and Stocks

Correlation & Price change

A.I.dvisor tells us that CSBR and SYRE have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CSBR and SYRE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CSBR
1D Price
Change %
CSBR100%
-1.93%
SYRE - CSBR
32%
Poorly correlated
+0.47%
SCNI - CSBR
27%
Poorly correlated
-3.90%
OABI - CSBR
25%
Poorly correlated
N/A
MREO - CSBR
24%
Poorly correlated
N/A
CVAC - CSBR
24%
Poorly correlated
-0.37%
More